From: Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study
 | New-onset headache (n = 95) |
---|---|
Headache region, n (%) | |
 Orbital | 49 (51.6) |
 Frontal | 29 (30.5) |
 Temporal | 54 (56.8) |
 Posterior | 42 (44.2) |
 Entire | 13 (13.7) |
 Others | 9 (9.5) |
Lateralization, n (%) | |
 Unilateral | 56 (58.9) |
 Bilateral | 43 (45.3) |
Headache duration, n (%) | |
 Less than 4 h | 47 (49.5) |
 4 to 72 h | 29 (30.5) |
 4 days or longer | 19 (20.0) |
Headache presentations, n (%) | |
 Pulsatile | 62 (65.3) |
 Pressing | 61 (64.2) |
 Sharp | 15 (15.8) |
 Thunderclap | 5 (5.3) |
Headache intensity, n (%) | |
 Mild | 20 (21.1) |
 Moderate | 47 (49.5) |
 Strong | 28 (29.5) |
 Headache days per month | 8.7 ± 7.9 |